Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-30 @ 3:20 AM
Study NCT ID:
NCT06888492
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-03-21
First Post:
2025-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)
Sponsor:
Hangzhou Jiayin Biotech Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-28
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-04-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-14
First Submit QC Date:
None
Study First Post Date:
2025-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-20
Last Update Post Date:
2025-03-21
Last Update Post Date Type:
ACTUAL